Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 100

Similar articles for PubMed (Select 23638448)

1.

Antidepressant-induced excessive sweating: clinical features and treatment with terazosin.

Mago R, Thase ME, Rovner BW.

Ann Clin Psychiatry. 2013 Aug;25(3):186-92. Epub 2013 May 1.

PMID:
23638448
2.

Comparison of terazosin and prazosin for treatment of vesico-urethral reflex dyssynergia in dogs.

Haagsman AN, Kummeling A, Moes ME, Mesu SJ, Kirpensteijn J.

Vet Rec. 2013 Jul 13;173(2):41. doi: 10.1136/vr.101326. Epub 2013 Jun 19.

PMID:
23784060
3.

Glycopyrrolate for antidepressant-associated excessive sweating.

Mago R.

J Clin Psychopharmacol. 2013 Apr;33(2):279-80. doi: 10.1097/JCP.0b013e31828567f2. No abstract available.

PMID:
23422382
4.

Effect of terazosin on sweating in patients with major depressive disorder receiving sertraline: a randomized controlled trial.

Ghaleiha A, Shahidi KM, Afzali S, Matinnia N.

Int J Psychiatry Clin Pract. 2013 Feb;17(1):44-7. doi: 10.3109/13651501.2012.687449. Epub 2012 Jun 26.

PMID:
22731399
5.

[Therapeutic value of moderate-dose oxybutynin in extensive hyperhidrosis].

Maillard H, Fenot M, Bara C, Célérier P.

Ann Dermatol Venereol. 2011 Oct;138(10):652-6. doi: 10.1016/j.annder.2011.07.002. Epub 2011 Aug 17. French.

PMID:
21978500
6.

WITHDRAWN: Terazosin for benign prostatic hyperplasia.

Wilt TJ, Howe RW, Rutks I, Macdonald R.

Cochrane Database Syst Rev. 2011 Sep 7;(9):CD003851. doi: 10.1002/14651858.CD003851.pub2. Review.

PMID:
21901686
7.

Effect of terazosin on lower urinary tract symptoms and pain due to double-J stent: a double-blind placebo-controlled randomized clinical trial.

Mokhtari G, Shakiba M, Ghodsi S, Farzan A, Heidari Nejad S, Esmaeili S.

Urol Int. 2011;87(1):19-22. doi: 10.1159/000323855. Epub 2011 May 18.

PMID:
21597261
8.

Open-label treatment with desvenlafaxine in postmenopausal women with major depressive disorder not responding to acute treatment with desvenlafaxine or escitalopram.

Soares CN, Thase ME, Clayton A, Guico-Pabia CJ, Focht K, Jiang Q, Kornstein SG, Ninan PT, Kane CP.

CNS Drugs. 2011 Mar;25(3):227-38. doi: 10.2165/11586460-000000000-00000.

PMID:
21323394
9.

Superior antidepressant efficacy results of agomelatine versus fluoxetine in severe MDD patients: a randomized, double-blind study.

Hale A, Corral RM, Mencacci C, Ruiz JS, Severo CA, Gentil V.

Int Clin Psychopharmacol. 2010 Nov;25(6):305-14. doi: 10.1097/YIC.0b013e32833a86aa.

PMID:
20856123
10.

[Milnacipran and venlafaxine at flexible doses (up to 200 mg/d) in the outpatient treatment of adults with moderate-to-severe major depressive disorder: a 24-week randomised, double blind exploratory study].

Olié JP, Gourion D, Montagne A, Rostin M, Poirier MF.

Encephale. 2009 Dec;35(6):595-604. doi: 10.1016/j.encep.2009.10.011. Epub . French.

PMID:
20004291
11.

Double-blind, placebo-controlled comparison of the antidepressant efficacy and tolerability of bupropion XR and venlafaxine XR.

Hewett K, Gee MD, Krishen A, Wunderlich HP, Le Clus A, Evoniuk G, Modell JG.

J Psychopharmacol. 2010 Aug;24(8):1209-16. doi: 10.1177/0269881109106953. Epub 2009 Nov 25.

PMID:
19939870
12.
13.
14.

[Amlodipine combined with terazosin reduces postvoid residual and the risk of acute urinary retention].

Yang C, Li YL, Fang J, Zhang X, Liu HP, Qin XH, Xu XP.

Zhonghua Nan Ke Xue. 2009 May;15(5):441-4. Chinese.

PMID:
19514558
15.

Duloxetine: a review of its use in the treatment of generalized anxiety disorder.

Carter NJ, McCormack PL.

CNS Drugs. 2009;23(6):523-41. doi: 10.2165/00023210-200923060-00006. Review.

PMID:
19480470
16.

Efficacy of combined amlodipine/terazosin therapy in male hypertensive patients with lower urinary tract symptoms: a randomized, double-blind clinical trial.

Liu H, Liu P, Mao G, Chen G, Wang B, Qin X, Na Y, Liu Z, Wang X, Xu X.

Urology. 2009 Jul;74(1):130-6. doi: 10.1016/j.urology.2008.11.051. Epub 2009 Apr 15.

PMID:
19371934
17.

Patient-rated troubling symptoms of depression instrument results correlate with traditional clinician- and patient-rated measures: a secondary analysis of a randomized, double-blind, placebo-controlled trial.

Pandina GJ, Revicki DA, Kleinman L, Turkoz I, Wu JH, Kujawa MJ, Mahmoud R, Gharabawi GM.

J Affect Disord. 2009 Nov;118(1-3):139-46. doi: 10.1016/j.jad.2009.02.019. Epub 2009 Mar 25.

PMID:
19321206
18.

Effects of adjunctive reboxetine in patients with duloxetine-resistant depression: a 12-week prospective study.

Seguí J, López-Muñoz F, Alamo C, Camarasa X, García-García P, Pardo A.

J Psychopharmacol. 2010 Aug;24(8):1201-7. doi: 10.1177/0269881109102641. Epub 2009 Mar 12.

PMID:
19282423
19.

An open-label tolerability and efficacy study of an aluminum sesquichlorohydrate topical foam in axillary and palmar primary hyperhidrosis.

Innocenzi D, Ruggero A, Francesconi L, Lacarrubba F, Nardone B, Micali G.

Dermatol Ther. 2008 Jul;21 Suppl 1:S27-30. doi: 10.1111/j.1529-8019.2008.00199.x.

PMID:
18727813
20.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk